Clearmind gets DSMB approval to test CMND-100 in AUD patients

Go back to Clearmind gets DSMB approval to test CMND-100 in AUD patients
(NASDAQ: CMND) Delayed: 0.79 -0.01 (1.25%)
Previous Close $0.80    52 Week High
Open $0.79    52 Week Low
Day High $0.80    P/E N/A 
Day Low $0.78    EPS
Volume 122,780